NanoViricides (NNVC) Competitors $1.41 +0.06 (+4.44%) As of 12:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock NNVC vs. CRVO, VTYX, AVTE, CRDL, JMAC, EPIX, CRBP, CLLS, IFRX, and IGMSShould you be buying NanoViricides stock or one of its competitors? The main competitors of NanoViricides include CervoMed (CRVO), Ventyx Biosciences (VTYX), Aerovate Therapeutics (AVTE), Cardiol Therapeutics (CRDL), Maxpro Capital Acquisition (JMAC), ESSA Pharma (EPIX), Corbus Pharmaceuticals (CRBP), Cellectis (CLLS), InflaRx (IFRX), and IGM Biosciences (IGMS). These companies are all part of the "pharmaceutical products" industry. NanoViricides vs. CervoMed Ventyx Biosciences Aerovate Therapeutics Cardiol Therapeutics Maxpro Capital Acquisition ESSA Pharma Corbus Pharmaceuticals Cellectis InflaRx IGM Biosciences CervoMed (NASDAQ:CRVO) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings. Does the MarketBeat Community believe in CRVO or NNVC? CervoMed received 23 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 82.14% of users gave CervoMed an outperform vote while only 0.00% of users gave NanoViricides an outperform vote. CompanyUnderperformOutperformCervoMedOutperform Votes2382.14% Underperform Votes517.86%NanoViricidesOutperform VotesNo VotesUnderperform Votes57100.00% Which has better earnings and valuation, CRVO or NNVC? CervoMed has higher revenue and earnings than NanoViricides. CervoMed is trading at a lower price-to-earnings ratio than NanoViricides, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCervoMed$7.14M10.73-$2.17M-$2.03-4.33NanoViricidesN/AN/A-$8.29M-$0.72-1.88 Do insiders and institutionals have more ownership in CRVO or NNVC? 25.1% of CervoMed shares are held by institutional investors. Comparatively, 10.3% of NanoViricides shares are held by institutional investors. 36.3% of CervoMed shares are held by company insiders. Comparatively, 4.6% of NanoViricides shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is CRVO or NNVC more profitable? NanoViricides has a net margin of 0.00% compared to CervoMed's net margin of -118.68%. CervoMed's return on equity of -44.11% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets CervoMed-118.68% -44.11% -39.81% NanoViricides N/A -87.90%-78.69% Do analysts rate CRVO or NNVC? CervoMed currently has a consensus target price of $27.50, suggesting a potential upside of 212.50%. Given CervoMed's stronger consensus rating and higher possible upside, analysts clearly believe CervoMed is more favorable than NanoViricides.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CervoMed 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 2.89NanoViricides 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, CRVO or NNVC? CervoMed has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500. Comparatively, NanoViricides has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Does the media favor CRVO or NNVC? In the previous week, CervoMed had 1 more articles in the media than NanoViricides. MarketBeat recorded 1 mentions for CervoMed and 0 mentions for NanoViricides. CervoMed's average media sentiment score of 1.92 beat NanoViricides' score of 0.00 indicating that CervoMed is being referred to more favorably in the media. Company Overall Sentiment CervoMed Very Positive NanoViricides Neutral SummaryCervoMed beats NanoViricides on 14 of the 18 factors compared between the two stocks. Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNVC vs. The Competition Export to ExcelMetricNanoViricidesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$21.12M$6.60B$5.41B$18.87BDividend YieldN/A3.20%5.44%4.15%P/E Ratio-1.877.0522.1832.40Price / SalesN/A273.45397.3128.58Price / CashN/A65.6738.2017.53Price / Book2.056.506.834.44Net Income-$8.29M$142.50M$3.20B$1.02B7 Day Performance1.50%8.32%5.76%3.35%1 Month Performance5.47%-5.61%-4.32%-5.48%1 Year Performance20.54%0.11%17.88%4.28% NanoViricides Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNVCNanoViricidesN/A$1.41+4.4%N/A+17.4%$22.05MN/A-1.9620CRVOCervoMed3.4816 of 5 stars$9.30-5.1%$27.50+195.7%-64.2%$80.94M$7.14M-4.584VTYXVentyx Biosciences1.8198 of 5 stars$1.13+5.6%$10.00+785.0%-70.3%$80.38MN/A-0.4830AVTEAerovate Therapeutics0.4161 of 5 stars$2.77+0.7%$2.25-18.8%-87.2%$80.29MN/A-0.9320CRDLCardiol Therapeutics1.6128 of 5 stars$0.97-4.0%$8.40+766.0%-39.2%$80.13MN/A-2.4920Gap UpJMACMaxpro Capital AcquisitionN/A$5.95+1.0%N/A+1,130.1%$79.90MN/A0.002,021EPIXESSA Pharma2.9646 of 5 stars$1.77-1.1%$9.50+436.7%-71.2%$78.57MN/A-2.5750CRBPCorbus Pharmaceuticals3.2717 of 5 stars$6.30+4.5%$59.13+838.5%-76.5%$77.06MN/A-1.3440Positive NewsGap UpCLLSCellectis2.7717 of 5 stars$1.38-4.8%$7.00+407.2%-39.6%$76.71M$41.51M-1.06290Analyst UpgradeIFRXInflaRx2.7955 of 5 stars$1.14+7.5%$9.00+689.5%-2.9%$76.53M$165,789.00-1.0660News CoverageIGMSIGM Biosciences3.1218 of 5 stars$1.28+4.9%$5.50+329.7%-82.7%$76.51M$2.68M-0.35190News CoverageGap Down Related Companies and Tools Related Companies CervoMed Alternatives Ventyx Biosciences Alternatives Aerovate Therapeutics Alternatives Cardiol Therapeutics Alternatives Maxpro Capital Acquisition Alternatives ESSA Pharma Alternatives Corbus Pharmaceuticals Alternatives Cellectis Alternatives InflaRx Alternatives IGM Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NNVC) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NNVC Stock Free NNVC Stock Alerts